Dunnigan lipodystrophy syndrome: French National Diagnosis and Care Protocol (PNDS; Protocole National de Diagnostic et de Soins).

Diagnosis Dunnigan disease Dunnigan syndrome Insulin-resistant diabetes Management Recommendation Type 2 familial partial lipodystrophy

Journal

Orphanet journal of rare diseases
ISSN: 1750-1172
Titre abrégé: Orphanet J Rare Dis
Pays: England
ID NLM: 101266602

Informations de publication

Date de publication:
19 04 2022
Historique:
received: 18 10 2021
accepted: 24 03 2022
entrez: 20 4 2022
pubmed: 21 4 2022
medline: 22 4 2022
Statut: epublish

Résumé

Dunnigan syndrome, or Familial Partial Lipodystrophy type 2 (FPLD2; ORPHA 2348), is a rare autosomal dominant disorder due to pathogenic variants of the LMNA gene. The objective of the French National Diagnosis and Care Protocol (PNDS; Protocole National de Diagnostic et de Soins), is to provide health professionals with a guide to optimal management and care of patients with FPLD2, based on a critical literature review and multidisciplinary expert consensus. The PNDS, written by members of the French National Reference Center for Rare Diseases of Insulin Secretion and Insulin Sensitivity (PRISIS), is available on the French Health Authority website (in French). Dunnigan syndrome is characterized by a partial atrophy of the subcutaneous adipose tissue and by an insulin resistance syndrome, associated with a risk of metabolic, cardiovascular and muscular complications. Its prevalence, assessed at 1/100.000 in Europe, is probably considerably underestimated. Thorough clinical examination is key to diagnosis. Biochemical testing frequently shows hyperinsulinemia, abnormal glucose tolerance and hypertriglyceridemia. Elevated hepatic transaminases (hepatic steatosis) and creatine phosphokinase, and hyperandrogenism in women, are common. Molecular analysis of the LMNA gene confirms diagnosis and allows for family investigations. Regular screening and multidisciplinary monitoring of the associated complications are necessary. Diabetes frequently develops from puberty onwards. Hypertriglyceridemia may lead to acute pancreatitis. Early atherosclerosis and cardiomyopathy should be monitored. In women, polycystic ovary syndrome is common. Overall, the management of patients with Dunnigan syndrome requires the collaboration of several health care providers. The attending physician, in conjunction with the national care network, will ensure that the patient receives optimal care through regular follow-up and screening. The various elements of this PNDS are described to provide such a support.

Identifiants

pubmed: 35440056
doi: 10.1186/s13023-022-02308-7
pii: 10.1186/s13023-022-02308-7
pmc: PMC9019936
doi:

Types de publication

Journal Article Practice Guideline

Langues

eng

Sous-ensembles de citation

IM

Pagination

170

Informations de copyright

© 2022. The Author(s).

Références

Nucleus. 2018;9(1):392-397
pubmed: 30131000
Am Heart J. 2015 Apr;169(4):587-93
pubmed: 25819867
Endocrine. 2019 Jun;64(3):500-511
pubmed: 30805888
J Clin Endocrinol Metab. 2020 Jul 1;105(7):
pubmed: 32193531
Orphanet J Rare Dis. 2020 Apr 2;15(1):81
pubmed: 32241282
J Clin Endocrinol Metab. 2017 May 1;102(5):1511-1519
pubmed: 28324110
Ann Endocrinol (Paris). 2012 Jun;73(3):170-89
pubmed: 22748602
J Plast Reconstr Aesthet Surg. 2011 Sep;64(9):1248-50
pubmed: 21561824
J Med Genet. 2017 Jun;54(6):413-416
pubmed: 28408391
Endocrinol Metab Clin North Am. 2017 Jun;46(2):539-554
pubmed: 28476236
CMAJ. 2007 Sep 25;177(7):743-5
pubmed: 17893350
Diabetes. 2000 Nov;49(11):1958-62
pubmed: 11078466
Eur J Endocrinol. 2021 Aug 27;185(4):453-462
pubmed: 34292171
J Hepatol. 2013 Jul;59(1):131-7
pubmed: 23439261
Eur J Endocrinol. 2013 Apr 15;168(5):771-8
pubmed: 23447519
Neurology. 2007 Feb 27;68(9):677-83
pubmed: 17325275
J Plast Reconstr Aesthet Surg. 2011 May;64(5):e121-4
pubmed: 21306965
J Clin Endocrinol Metab. 2002 Jul;87(7):3110-7
pubmed: 12107209
Diabetes Metab Syndr Obes. 2017 Sep 13;10:375-383
pubmed: 29066925
J Diabetes Metab. 2016 Mar;7(3):
pubmed: 27642538
Endocrinol Metab Clin North Am. 2016 Dec;45(4):783-797
pubmed: 27823605
Circ Cardiovasc Genet. 2017 Dec;10(6):
pubmed: 29237675
Diabetes Metab Syndr Obes. 2020 May 06;13:1531-1544
pubmed: 32440182
J Clin Endocrinol Metab. 2015 May;100(5):1802-10
pubmed: 25734254
BMC Pediatr. 2016 Mar 14;16:38
pubmed: 26976018
J Pathol. 2012 Jan;226(2):316-25
pubmed: 21953297
Endocrine. 2017 Nov;58(2):262-266
pubmed: 28993984
Arterioscler Thromb Vasc Biol. 2013 Sep;33(9):2162-71
pubmed: 23846499
Plast Reconstr Surg. 2013 Mar;131(3):499-506
pubmed: 23142937
Circulation. 2019 Jul 23;140(4):293-302
pubmed: 31155932
Curr Med Res Opin. 2019 Mar;35(3):543-552
pubmed: 30296183
Skeletal Radiol. 2016 Nov;45(11):1495-506
pubmed: 27631079
J Clin Endocrinol Metab. 2004 Nov;89(11):5337-46
pubmed: 15531479
Diabetes Metab. 2021 Mar;47(2):101185
pubmed: 32846201
Nucleus. 2018 Jan 1;9(1):235-248
pubmed: 29578370
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
J Clin Endocrinol Metab. 2008 Jun;93(6):2223-9
pubmed: 18364375
Ann Endocrinol (Paris). 2020 Feb;81(1):51-60
pubmed: 31982105
J Clin Nurs. 2018 May;27(9-10):1958-1968
pubmed: 29516553
J Clin Endocrinol Metab. 2016 Dec;101(12):4500-4511
pubmed: 27710244
J Clin Endocrinol Metab. 2011 May;96(5):E856-62
pubmed: 21346069
Nat Genet. 2000 Feb;24(2):153-6
pubmed: 10655060
J Clin Endocrinol Metab. 2013 Aug;98(8):E1410-3
pubmed: 23783098
Diabetes. 2020 Feb;69(2):249-258
pubmed: 31836692
Endocrine. 2020 Jun;68(3):518-525
pubmed: 32103407
Clin Gastroenterol Hepatol. 2019 Jan;17(1):54-64.e1
pubmed: 30196155
J Clin Endocrinol Metab. 2019 Apr 1;104(4):1099-1108
pubmed: 30418556
Phys Med Rehabil Clin N Am. 2012 Aug;23(3):675-87
pubmed: 22938881
Curr Diab Rep. 2018 Oct 29;18(12):139
pubmed: 30370487
Am J Gastroenterol. 2005 Oct;100(10):2218-24
pubmed: 16181372
Arterioscler Thromb Vasc Biol. 2003 Jan 1;23(1):111-6
pubmed: 12524233
Sleep Breath. 2009 Nov;13(4):425-7
pubmed: 19418082
Ann Endocrinol (Paris). 2012 Nov;73(5):469-87
pubmed: 23078975
Gastroenterology. 2018 May;154(6):1602-1619.e1
pubmed: 29549040
Eur Heart J. 2020 Jan 1;41(1):111-188
pubmed: 31504418
Diabet Med. 2017 Dec;34(12):1792-1794
pubmed: 29044799
Clin Endocrinol (Oxf). 2017 May;86(5):698-707
pubmed: 28199729
GE Port J Gastroenterol. 2019 Aug;26(5):362-369
pubmed: 31559327
Diabetes Metab. 2019 Sep;45(4):382-389
pubmed: 30287275
Eur Heart J. 2016 Jun 14;37(23):1850-8
pubmed: 26792875

Auteurs

H Mosbah (H)

Endocrinology, Diabetology and Reproductive Endocrinology Department, Assistance Publique-Hôpitaux de Paris, Saint-Antoine University Hospital, National Reference Center for Rare Diseases of Insulin Secretion and Insulin Sensitivity (PRISIS), Paris, France.
Sorbonne University, Inserm UMR_S938, Saint-Antoine Research Centre, Institute of Cardiometabolism and Nutrition, Paris, France.

B Donadille (B)

Endocrinology, Diabetology and Reproductive Endocrinology Department, Assistance Publique-Hôpitaux de Paris, Saint-Antoine University Hospital, National Reference Center for Rare Diseases of Insulin Secretion and Insulin Sensitivity (PRISIS), Paris, France.

C Vatier (C)

Endocrinology, Diabetology and Reproductive Endocrinology Department, Assistance Publique-Hôpitaux de Paris, Saint-Antoine University Hospital, National Reference Center for Rare Diseases of Insulin Secretion and Insulin Sensitivity (PRISIS), Paris, France.
Sorbonne University, Inserm UMR_S938, Saint-Antoine Research Centre, Institute of Cardiometabolism and Nutrition, Paris, France.

S Janmaat (S)

Endocrinology, Diabetology and Reproductive Endocrinology Department, Assistance Publique-Hôpitaux de Paris, Saint-Antoine University Hospital, National Reference Center for Rare Diseases of Insulin Secretion and Insulin Sensitivity (PRISIS), Paris, France.
Sorbonne University, Inserm UMR_S938, Saint-Antoine Research Centre, Institute of Cardiometabolism and Nutrition, Paris, France.

M Atlan (M)

Sorbonne University, Inserm UMR_S938, Saint-Antoine Research Centre, Institute of Cardiometabolism and Nutrition, Paris, France.
Plastic Surgery Department, Assistance Publique-Hôpitaux de Paris, Tenon Hospital, Paris, France.

C Badens (C)

Department of Genetics, Assistance Publique-Hôpitaux de Marseille, Marseille, France.

P Barat (P)

Pediatric Endocrinology Unit, Bordeaux University Hospitals, Bordeaux, France.

S Béliard (S)

Nutrition Department, Assistance Publique-Hôpitaux de Marseille, La Conception Hospital, Marseille, France.

J Beltrand (J)

Paediatric Endocrinology Department, Assistance Publique-Hôpitaux de Paris, Necker Hospital, Paris University, Paris, France.

R Ben Yaou (R)

Assistance Publique-Hôpitaux de Paris, Pitié-Salpêtrière Hospital, Myology Institute, Sorbonne University, Paris, France.

E Bismuth (E)

Paediatric Endocrinology Department, Assistance Publique-Hôpitaux de Paris, Robert Debré Hospital, Paris University, Paris, France.

F Boccara (F)

Cardiology Department, Assistance Publique-Hôpitaux de Paris, St Antoine Hospital, Sorbonne University, Paris, France.

B Cariou (B)

Endocrinology Department, Nantes University Hospitals, Guillaume et René Laennec Hospital, Nantes University, Nantes, France.

M Chaouat (M)

Plastic Surgery Department, Assistance Publique-Hôpitaux de Paris, St Louis Hospital, Paris University, Paris, France.

G Charriot (G)

French Lipodystrophy Association (AFLIP; Association Française des Lipodystrophies), Pierrevert, France.

S Christin-Maitre (S)

Endocrinology, Diabetology and Reproductive Endocrinology Department, Assistance Publique-Hôpitaux de Paris, Saint-Antoine University Hospital, National Reference Center for Rare Diseases of Insulin Secretion and Insulin Sensitivity (PRISIS), Paris, France.
Sorbonne University, Inserm UMR_S938, Saint-Antoine Research Centre, Institute of Cardiometabolism and Nutrition, Paris, France.
Sorbonne University, Inserm UMR_S933, Paris, France.

M De Kerdanet (M)

Paediatric Endocrinology Department, Rennes University Hospitals, South Hospital, Rennes, France.

B Delemer (B)

Endocrinology Department, Reims University Hospitals, Robert Debré Hospital, Reims, France.

E Disse (E)

Endocrinology Department, Lyon University Hospitals, South Lyon Civil Hospital, Lyon University, Pierre Benite, France.

N Dubois (N)

Nutrition Department, Assistance Publique-Hôpitaux de Marseille, La Conception Hospital, Marseille, France.

B Eymard (B)

Assistance Publique-Hôpitaux de Paris, Pitié-Salpêtrière Hospital, Myology Institute, Sorbonne University, Paris, France.

B Fève (B)

Endocrinology, Diabetology and Reproductive Endocrinology Department, Assistance Publique-Hôpitaux de Paris, Saint-Antoine University Hospital, National Reference Center for Rare Diseases of Insulin Secretion and Insulin Sensitivity (PRISIS), Paris, France.
Sorbonne University, Inserm UMR_S938, Saint-Antoine Research Centre, Institute of Cardiometabolism and Nutrition, Paris, France.

O Lascols (O)

Sorbonne University, Inserm UMR_S938, Saint-Antoine Research Centre, Institute of Cardiometabolism and Nutrition, Paris, France.
Molecular Biology and Genetics Department, Assistance Publique-Hôpitaux de Paris, Saint-Antoine University Hospital, Paris, France.

P Mathurin (P)

Hepatology Department, Lille 2 University Hospitals, Lille University, Lille, France.

E Nobécourt (E)

Endocrinology Department, La Reunion University Hospitals, Reunion South Hospital, St Pierre de la Reunion, France.

A Poujol-Robert (A)

Hepatology Department, Assistance Publique-Hôpitaux de Paris, Saint-Antoine Hospital, Sorbonne University, Paris, France.

G Prevost (G)

Endocrinology Department, Rouen University Hospitals, Bois-Guillaume Hospital, Rouen, France.

P Richard (P)

Cardiogenetics and Myogenetics Department, Assistance Publique-Hôpitaux de Paris, Pitie Salpêtrière Hospital, Sorbonne University, Paris, France.

J Sellam (J)

Sorbonne University, Inserm UMR_S938, Saint-Antoine Research Centre, Institute of Cardiometabolism and Nutrition, Paris, France.
Rhumatology Department, Assistance Publique-Hôpitaux de Paris, Saint-Antoine Hospital, Sorbonne University, Paris, France.

I Tauveron (I)

Endocrinology Department, Clermont-Ferrand University Hospital, Clermont Auvergne University, Clermont-Ferrand, France.

D Treboz (D)

French Lipodystrophy Association (AFLIP; Association Française des Lipodystrophies), Pierrevert, France.

B Vergès (B)

Endocrinology-Diabetology Department, Dijon University Hospital, François Mitterand Hospital, Bourgogne University, Dijon, France.

V Vermot-Desroches (V)

Endocrinology, Diabetology and Reproductive Endocrinology Department, Assistance Publique-Hôpitaux de Paris, Saint-Antoine University Hospital, National Reference Center for Rare Diseases of Insulin Secretion and Insulin Sensitivity (PRISIS), Paris, France.

K Wahbi (K)

Cardiology Department, Assistance Publique-Hôpitaux de Paris, Cochin Hospital, Paris University, Paris, France.

I Jéru (I)

Sorbonne University, Inserm UMR_S938, Saint-Antoine Research Centre, Institute of Cardiometabolism and Nutrition, Paris, France.
Molecular Biology and Genetics Department, Assistance Publique-Hôpitaux de Paris, Saint-Antoine University Hospital, Paris, France.

M C Vantyghem (MC)

Endocrinology Department, Lille 2 University Hospitals, Lille University, Lille, France.

C Vigouroux (C)

Endocrinology, Diabetology and Reproductive Endocrinology Department, Assistance Publique-Hôpitaux de Paris, Saint-Antoine University Hospital, National Reference Center for Rare Diseases of Insulin Secretion and Insulin Sensitivity (PRISIS), Paris, France. corinne.vigouroux@aphp.fr.
Sorbonne University, Inserm UMR_S938, Saint-Antoine Research Centre, Institute of Cardiometabolism and Nutrition, Paris, France. corinne.vigouroux@aphp.fr.
Molecular Biology and Genetics Department, Assistance Publique-Hôpitaux de Paris, Saint-Antoine University Hospital, Paris, France. corinne.vigouroux@aphp.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH